Brian Nicholas Harvey
Chief Financial OfficerMr. Brian Nicholas Harvey, MBA, also known as Nick, has been the Chief Financial Officer at Adicet Bio, Inc since September 15, 2020. Previously, he served as the Chief Financial Officer since July 2018 and the Executive Vice President and Treasurer since October 2018 of Centrexion Therapeutics Corporation until December 2019, then as Senior Advisor through January 2020. He has been an Advisor of Radius Health, Inc. since May 15, 2017 and served as its Chief Financial Officer from December 2006 to May2017and Senior Vice President from November 2011 to May 15, 2017. Mr. Harvey has been Treasurer of Radius Health, Inc. since November 2011 and served as its Secretary since November 2011. He serves as an Executive Officer of Transfusion Technologies Corporation served as the Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer of MPM Acquisition Corp. He served as the Chief Financial Officer of QRxPharma Limited from July 2006 to March 2007. From June 2017 through June 2018, he served as an independent consultant to private and public life science companies. Mr. Harvey served as the President and Interim Chief Executive Officer of Transcend Therapeutics Inc. since August 1998. He served as the Chief Financial officer, Principal Accounting Officer, Senior Vice President of Finance and Secretary of Transcend Therapeutics Inc. since October 1997. He served as Vice President of Finance at Transcend Therapeutics Inc. from December 1992 to October 1997. Mr. Harvey served as the Managing Director at Shiprock Capital LLC. Prior to joining Shiprock Capital in 2003, he held various financial and business development positions from 1992 to 2002 with several ventures backed technology and life sciences companies, including Computer Power Group, Transfusion Technologies Corporation and LifetecNet. He serves as a Director of Shiprock Capital LLC and Prominence Networks. He has been a Director of Passport Systems Inc. since 2007. He served as a Director of MPM Acquisition Corp. since November 22, 2010. He served as Director of Transcend Therapeutics Inc. since August 1998. Mr. Harvey holds an Undergraduate Degree in Economics and a Law Degree from Australian National University and an M.B.A. from the Harvard Business School.
公司職務
- 公司名稱Adicet Bio, Inc.股票代碼ACET職務Chief Financial Officer關聯證券共事同僚
